SVRA
Savara Inc. NASDAQ Listed Apr 28, 2017$5.78
After hrs
$5.78
-0.00%
Mkt Cap $1.3B
52w Low $2.05
76.3% of range
52w High $6.94
50d MA $5.26
200d MA $5.10
P/E (TTM)
-10.3x
EV/EBITDA
—
P/B
6.3x
Debt/Equity
0.1x
ROE
-58.5%
P/FCF
-12.7x
RSI (14)
69.60
ATR (14)
$0.26
Beta
0.31
50d MA
$5.26
200d MA
$5.10
Avg Volume
1.6M
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
CIK (SEC)
Phone
512 614 1848
Building III · Langhorne, TX 78746 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | BMO | -0.14 | -0.15 | -7.1% | 5.08 | -5.1% | +3.7% | +0.0% | -4.6% | -2.4% | -3.9% | — |
| Mar 13, 2026 | BMO | -0.12 | -0.13 | -8.3% | 5.25 | +1.3% | -0.4% | -1.5% | -2.1% | +2.4% | -3.9% | — |
| Nov 12, 2025 | BMO | -0.13 | -0.14 | -7.7% | 4.12 | +0.5% | +3.4% | +0.9% | -2.3% | -0.7% | +10.3% | — |
| Aug 13, 2025 | BMO | -0.12 | -0.14 | -16.7% | 2.70 | +0.0% | +11.5% | +1.0% | +0.3% | +0.0% | +1.3% | — |
| May 13, 2025 | BMO | -0.12 | -0.12 | +0.0% | 2.97 | -0.7% | +0.7% | +4.0% | -1.3% | +2.0% | +0.3% | — |
| Mar 27, 2025 | BMO | -0.11 | -0.13 | -18.2% | 2.78 | +2.5% | +4.7% | -4.8% | +3.2% | +5.2% | -3.7% | — |
| Nov 12, 2024 | BMO | -0.11 | -0.11 | +0.0% | 3.83 | -4.2% | -15.1% | -1.8% | -6.6% | -0.7% | -0.7% | — |
| Aug 12, 2024 | BMO | -0.11 | -0.12 | -9.1% | 4.10 | +2.4% | +1.0% | +2.9% | +5.9% | -3.5% | +2.3% | — |
| May 9, 2024 | BMO | -0.10 | -0.11 | -10.0% | 5.07 | -3.2% | -8.1% | -1.5% | +4.8% | +0.4% | -2.3% | — |
| Mar 7, 2024 | BMO | -0.11 | -0.09 | +18.2% | 5.59 | -2.1% | -5.2% | -7.4% | +0.2% | -0.6% | -4.7% | — |
| Nov 9, 2023 | BMO | -0.07 | -0.10 | -42.9% | 3.41 | +7.2% | +1.8% | -0.3% | +6.4% | -0.5% | -1.5% | — |
| Aug 10, 2023 | BMO | -0.08 | -0.07 | +12.5% | 3.84 | +1.6% | +1.0% | -1.5% | +1.0% | -8.0% | -3.1% | — |
| May 15, 2023 | AMC | -0.07 | -0.07 | +0.0% | 1.98 | +6.1% | +9.1% | +14.8% | +3.2% | +2.3% | -1.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | Oppenheimer | Reiterates | Outperform | $11 | $4.94 | $4.97 | +0.6% | +3.6% | +0.8% | -2.7% | -3.4% | +8.0% |
| Dec 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.47 | $6.56 | +1.4% | -0.5% | -0.6% | +0.8% | -1.9% | -3.5% |
| Dec 18 | Wells Fargo | Maintains | Overweight → Overweight | — | $6.11 | $6.24 | +2.1% | -0.8% | -0.2% | +6.9% | -0.5% | -0.6% |
| Nov 14 | Oppenheimer | Maintains | Outperform → Outperform | — | $4.26 | $4.32 | +1.4% | +0.9% | -2.3% | -0.7% | +10.3% | +1.5% |
| Nov 13 | Citizens | Maintains | Market Outperform → Market Outperform | — | $4.12 | $4.14 | +0.5% | +3.4% | +0.9% | -2.3% | -0.7% | +10.3% |
| Oct 23 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.11 | $4.20 | +2.2% | +0.2% | +5.8% | +0.5% | +0.7% | -1.6% |
| Sep 9 | Guggenheim | Maintains | Buy → Buy | — | $3.85 | $3.81 | -1.0% | -0.8% | +0.3% | -6.3% | -0.8% | +1.4% |
| Sep 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.72 | $3.85 | +3.5% | +3.5% | -0.8% | +0.3% | -6.3% | -0.8% |
| Sep 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.31 | $3.36 | +1.5% | +3.3% | +4.7% | +3.9% | +3.5% | -0.8% |
| Aug 15 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $3.01 | $3.28 | +9.0% | +1.0% | +0.3% | +0.0% | +1.3% | -1.3% |
| Aug 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.01 | $3.28 | +9.0% | +1.0% | +0.3% | +0.0% | +1.3% | -1.3% |
| Jun 1 | Oppenheimer | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| May 29 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $2.13 | $1.99 | -6.6% | +5.2% | +1.8% | +5.3% | +0.0% | +3.8% |
| May 28 | Evercore ISI | Maintains | In Line → In Line | — | $1.94 | $1.94 | +0.0% | +9.8% | +5.2% | +1.8% | +5.3% | +0.0% |
| May 28 | Guggenheim | Maintains | Buy → Buy | — | $1.94 | $1.94 | +0.0% | +9.8% | +5.2% | +1.8% | +5.3% | +0.0% |
| May 28 | Wells Fargo | Maintains | Overweight → Overweight | — | $1.94 | $1.94 | +0.0% | +9.8% | +5.2% | +1.8% | +5.3% | +0.0% |
| Mar 31 | Evercore ISI | Maintains | In Line → Hold | — | $2.91 | $2.81 | -3.4% | -4.8% | +3.2% | +5.2% | -3.7% | -1.7% |
| Mar 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.78 | $2.85 | +2.5% | +4.7% | -4.8% | +3.2% | +5.2% | -3.7% |
| Dec 19 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $3.02 | $3.09 | +2.3% | +7.0% | +0.0% | +0.6% | -1.5% | +2.5% |
| Nov 13 | Evercore ISI | Downgrade | Outperform → In Line | — | $3.83 | $3.67 | -4.2% | -15.1% | -1.8% | -6.6% | -0.7% | -0.7% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.83 | $3.67 | -4.2% | -15.1% | -1.8% | -6.6% | -0.7% | -0.7% |
| Oct 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.74 | $3.71 | -0.8% | +1.1% | -3.4% | -1.4% | +4.7% | -2.9% |
| Oct 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.24 | $4.20 | -0.9% | -5.9% | -2.3% | -2.3% | +0.3% | -2.1% |
| Oct 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.24 | $4.20 | -0.9% | -5.9% | -2.3% | -2.3% | +0.3% | -2.1% |
| Sep 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.42 | $4.36 | -1.4% | -3.6% | +3.3% | -1.8% | -1.9% | -0.9% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.14 | $4.20 | +1.4% | +2.9% | +5.9% | -3.5% | +2.3% | +1.1% |
| Aug 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.10 | $4.20 | +2.4% | +1.0% | +2.9% | +5.9% | -3.5% | +2.3% |
| Jun 27 | Guggenheim | Maintains | Buy → Buy | — | $3.84 | $3.85 | +0.3% | -0.8% | +5.8% | +15.1% | -7.3% | +0.7% |
| Jun 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.84 | $3.85 | +0.3% | -0.8% | +5.8% | +15.1% | -7.3% | +0.7% |
| Jun 26 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.80 | $4.42 | +16.3% | +1.1% | -0.8% | +5.8% | +15.1% | -7.3% |
| May 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $4.17 | $4.22 | +1.2% | +3.1% | +0.7% | -3.7% | -2.2% | +1.7% |
| May 16 | Evercore ISI | Maintains | Outperform → Outperform | — | $4.83 | $4.77 | -1.2% | -2.3% | -5.1% | -6.9% | +3.1% | +0.7% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.66 | $4.64 | -0.4% | -1.5% | +4.8% | +0.4% | -2.3% | -5.1% |
| May 6 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.71 | $4.74 | +0.6% | +5.1% | +6.3% | -5.1% | +1.6% | -8.1% |
| Apr 19 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.79 | $4.75 | -0.8% | +0.4% | -2.3% | -0.2% | -9.6% | +5.0% |
| Apr 18 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.96 | $4.95 | -0.2% | -3.4% | +0.4% | -2.3% | -0.2% | -9.6% |
| Mar 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.30 | $5.29 | -0.2% | -7.4% | +0.2% | -0.6% | -4.7% | +1.1% |
| Mar 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.16 | $5.26 | +1.9% | +6.8% | -1.5% | -0.2% | +3.1% | -5.2% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.47 | $3.47 | +0.0% | -0.3% | +6.4% | -0.5% | -1.5% | +3.5% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.88 | $3.97 | +2.3% | -1.5% | +1.0% | -8.0% | -3.1% | +2.9% |
| May 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.16 | $2.16 | +0.0% | +14.8% | +3.2% | +2.3% | -1.5% | -1.2% |
| Apr 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.83 | $1.82 | -0.5% | -6.6% | -1.2% | +1.8% | +0.0% | +0.6% |
| Apr 3 | Jefferies | Downgrade | Buy → Hold | — | $1.95 | $1.92 | -1.5% | -6.2% | -6.6% | -1.2% | +1.8% | +0.0% |
| Mar 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $1.77 | $2.25 | +27.1% | +15.8% | +13.7% | -8.6% | -2.8% | -6.3% |
| Mar 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $1.57 | $1.75 | +11.5% | +12.7% | +15.8% | +13.7% | -8.6% | -2.8% |
| Dec 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.15 | $1.11 | -3.5% | +8.7% | -1.6% | +4.9% | +5.4% | +0.0% |
| Jun 13 | JMP Securities | Downgrade | Outperform → Market Perform | — | $10.57 | $2.67 | -74.7% | -75.2% | -6.1% | -3.3% | +0.0% | +13.9% |
| Jun 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $9.42 | $10.85 | +15.2% | +21.1% | +0.2% | +4.6% | +1.3% | +3.0% |
| May 25 | H.C. Wainwright | Maintains | Buy → Buy | — | $8.55 | $8.99 | +5.1% | +3.9% | +17.6% | +4.1% | -6.9% | -4.2% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $8.60 | $8.60 | +0.0% | +7.9% | +0.3% | -0.9% | +0.2% | +1.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Lowrance David L | Chief Financial Officer | Sell | 394,528 | $5.68 | $2.2M | 536,032 | +1.58% | — |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vr Adviser, Llc | 13,740,375 | $83M | Added | Dec 2025 |
| 2 | Deerfield Management Company, L.p. | 13,569,000 | $74M | — | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 7,783,913 | $43M | New | Mar 2026 |
| 4 | Rtw Investments, Lp | 5,952,380 | $32M | — | Mar 2026 |
| 5 | Morgan Stanley | 4,675,792 | $28M | Added | Dec 2025 |
| 6 | Marshall Wace, Llp | 4,514,348 | $25M | Reduced | Mar 2026 |
| 7 | Woodline Partners Lp | 4,245,119 | $23M | — | Mar 2026 |
| 8 | Rosalind Advisors, Inc. | 3,203,721 | $17M | Reduced | Mar 2026 |
| 9 | D.e. Shaw & Co | 2,111,882 | $12M | Added | Mar 2026 |
| 10 | Nan Fung Trinity (Hk) Ltd | 1,842,350 | $10M | Added | Mar 2026 |
| 11 | Superstring Capital Management Lp | 1,585,977 | $9M | Added | Mar 2026 |
| 12 | Adar1 Capital Management, Llc | 1,464,535 | $8M | New | Mar 2026 |
| 13 | Vanguard Portfolio Management Llc | 1,375,477 | $8M | New | Mar 2026 |
| 14 | Longaeva Partners L.p. | 1,275,000 | $7M | Added | Mar 2026 |
| 15 | Eversource Wealth Advisors, Llc | 55,411 | $7M | New | Mar 2026 |
| 16 | Northern Trust Corp | 1,189,994 | $6M | Added | Mar 2026 |
| 17 | Bnp Paribas Asset Management Holding S.a. | 1,052,893 | $6M | Reduced | Mar 2026 |
| 18 | Algert Global Llc | 864,614 | $5M | New | Mar 2026 |
| 19 | Voya Investment Management Llc | 751,255 | $5M | Reduced | Dec 2025 |
| 20 | Citadel Advisors Llc | 798,735 | $4M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.29B
Enterprise Value
$1.08B
P/E (TTM)
-10.32x
Forward P/E
—
PEG Ratio
-1.08x
P/B
6.33x
P/S
—
P/FCF
-12.72x
EV/EBITDA
—
Shares Out
222.4M
Financials (TTM)
Revenue
$0
Net Income
-$129.5M
EBITDA
-$129.3M
Free Cash Flow
-$101.1M
Op Cash Flow
-$101.0M
EPS Basic
$-0.53
EPS Diluted
$-0.56
EPS Forward
$-0.48
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$253.4M
Total Liab.
$50.3M
Total Equity
$203.1M
Cash
$235.7M
LT Debt
$29.9M
Book Value/Sh
$0.91
Debt/Equity
0.15x
Current Ratio
11.85
Quick Ratio
11.85
Returns & Growth
ROE
-58.5%
ROA
-46.9%
ROIC
-53.0%
Rev Growth YoY
+0.0%
EPS Growth YoY
-10.4%
Price Returns
2W
-1.3%
1M
-0.8%
3M
-13.6%
6M
-17.3%
12M
+128.1%
Technicals
52W High
$6.94
52W Low
$2.05
50d MA
$5.26
200d MA
$5.10
RSI (14)
69.60
ATR (14)
$0.26
Beta
0.31
Avg Volume
1.6M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$10.00
High
$10.00
Low
$10.00
Median
$10.00
Data updated apr 27, 2026 3:39am
· Source: financialmodelingprep.com